Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-054884

Director sold 22,000 shares at $6.00 ($132,070)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2025-12-01 Sale 10b5-1 −22,000 $6.00 $132,070 1,188,391 D
Open-market sales · 22,000 sh · avg $6.00 · $132,070
Loading xslF345X05/wk-form4_1764722880.xml…